These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 36314239)

  • 1. Emerging and re-emerging KPC-producing hypervirulent
    Zhang B; Xu X; Song X; Wen Y; Zhu Z; Lv J; Xie X; Chen L; Tang YW; Du H
    Emerg Microbes Infect; 2022 Dec; 11(1):2735-2745. PubMed ID: 36314239
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bloodstream Infections Caused by
    Hu H; Zhang Y; Zhang P; Wang J; Yuan Q; Shi W; Zhang S; Feng H; Chen Y; Yu M; Chen H; Jiang Y; Yang Q; Qu T
    Front Cell Infect Microbiol; 2021; 11():756782. PubMed ID: 34790589
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Emergence of a KPC-90 Variant that Confers Resistance to Ceftazidime-Avibactam in an ST463 Carbapenem-Resistant Pseudomonas aeruginosa Strain.
    Tu Y; Wang D; Zhu Y; Li J; Jiang Y; Wu W; Li X; Zhou H
    Microbiol Spectr; 2022 Feb; 10(1):e0186921. PubMed ID: 35019766
    [TBL] [Abstract][Full Text] [Related]  

  • 4.
    Li Y; Fang L; Dong M; Cai H; Hua X; Jiang Y; Yu Y; Yang Q
    Antimicrob Agents Chemother; 2023 Nov; 67(11):e0067523. PubMed ID: 37819082
    [No Abstract]   [Full Text] [Related]  

  • 5. Emergence and Expansion of a Carbapenem-Resistant Pseudomonas aeruginosa Clone Are Associated with Plasmid-Borne
    Hu Y; Liu C; Wang Q; Zeng Y; Sun Q; Shu L; Lu J; Cai J; Wang S; Zhang R; Wu Z
    mSystems; 2021 May; 6(3):. PubMed ID: 34006625
    [No Abstract]   [Full Text] [Related]  

  • 6. Prevalence, Risk Factors, and Molecular Epidemiology of Intestinal Carbapenem-Resistant Pseudomonas aeruginosa.
    Hu Y; Qing Y; Chen J; Liu C; Lu J; Wang Q; Zhen S; Zhou H; Huang L; Zhang R
    Microbiol Spectr; 2021 Dec; 9(3):e0134421. PubMed ID: 34817230
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of Ceftazidime-Avibactam Treatment in the Emergence of Novel KPC Variants in the ST307-Klebsiella pneumoniae High-Risk Clone and Consequences for Their Routine Detection.
    Hernández-García M; Castillo-Polo JA; Cordero DG; Pérez-Viso B; García-Castillo M; Saez de la Fuente J; Morosini MI; Cantón R; Ruiz-Garbajosa P
    J Clin Microbiol; 2022 Mar; 60(3):e0224521. PubMed ID: 35107303
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of carbapenem-resistant Pseudomonas aeruginosa clinical isolates, carrying multiple genes coding for this antibiotic resistance.
    Rizek C; Fu L; Dos Santos LC; Leite G; Ramos J; Rossi F; Guimaraes T; Levin AS; Costa SF
    Ann Clin Microbiol Antimicrob; 2014 Sep; 13():43. PubMed ID: 25179208
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel KPC-113 variant conferring carbapenem and ceftazidime-avibactam resistance in a multidrug-resistant Pseudomonas aeruginosa isolate.
    Yang Q; Li Y; Fang L; Lei T; Cai H; Hua X; Zheng M; Yu Y
    Clin Microbiol Infect; 2023 Mar; 29(3):387.e7-387.e14. PubMed ID: 36252790
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antimicrobial Susceptibility Profiles To Predict the Presence of Carbapenemase Genes among Carbapenem-Resistant Pseudomonas aeruginosa Isolates.
    Vallabhaneni S; Huang JY; Grass JE; Bhatnagar A; Sabour S; Lutgring JD; Campbell D; Karlsson M; Kallen AJ; Nazarian E; Snavely EA; Morris S; Wang C; Lee R; Koag M; Lewis R; Garcia B; ; Brown AC; Walters MS
    J Clin Microbiol; 2021 May; 59(6):. PubMed ID: 33762362
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Deciphering mechanisms affecting cefepime-taniborbactam in vitro activity in carbapenemase-producing Enterobacterales and carbapenem-resistant Pseudomonas spp. isolates recovered during a surveillance study in Spain.
    Hernández-García M; García-Castillo M; Nieto-Torres M; Bou G; Ocampo-Sosa A; Pitart C; Gracia-Ahufinger I; Mulet X; Pascual Á; Tormo N; Oliver A; Ruiz-Garbajosa P; Cantón R
    Eur J Clin Microbiol Infect Dis; 2024 Feb; 43(2):279-296. PubMed ID: 38041722
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characteristics of rare ST463 carbapenem-resistant Pseudomonas aeruginosa clinical isolates from blood.
    Zhang X; Tang M; Xu Y; Xu M; Qian C; Zheng X; Zhou T; Wu Q
    J Glob Antimicrob Resist; 2023 Mar; 32():122-130. PubMed ID: 36801256
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Analysis of the resistance mechanism and homology of carbapenems-resistant Pseudomonas aeruginosa].
    Liu Y; Deng Q; Yu Y; Cao X; Xu Q; Wan L
    Zhonghua Shao Shang Za Zhi; 2014 Feb; 30(1):15-20. PubMed ID: 24684984
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Emergence of ceftazidime/avibactam resistance in carbapenem-resistant Klebsiella pneumoniae in China.
    Zhang P; Shi Q; Hu H; Hong B; Wu X; Du X; Akova M; Yu Y
    Clin Microbiol Infect; 2020 Jan; 26(1):124.e1-124.e4. PubMed ID: 31494252
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outbreak of IncX8 Plasmid-Mediated KPC-3-Producing Enterobacterales Infection, China.
    Chen L; Ai W; Zhou Y; Wu C; Guo Y; Wu X; Wang B; Rao L; Xu Y; Zhang J; Chen L; Yu F
    Emerg Infect Dis; 2022 Jul; 28(7):1421-1430. PubMed ID: 35731165
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activity of Ceftolozane-Tazobactam against Carbapenem-Resistant, Non-Carbapenemase-Producing Pseudomonas aeruginosa and Associated Resistance Mechanisms.
    Wi YM; Greenwood-Quaintance KE; Schuetz AN; Ko KS; Peck KR; Song JH; Patel R
    Antimicrob Agents Chemother; 2018 Jan; 62(1):. PubMed ID: 29133568
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regional outbreak of multidrug-resistant
    Tadese BK; Nutt A; Chaudhary I; Offiong C; Darkoh C
    Infect Control Hosp Epidemiol; 2023 Jan; 44(1):96-98. PubMed ID: 34593069
    [No Abstract]   [Full Text] [Related]  

  • 18. Emergence of Hypervirulent Carbapenem-Resistant Klebsiella pneumoniae Coharboring a
    Ahmed MAEE; Yang Y; Yang Y; Yan B; Chen G; Hassan RM; Zhong LL; Chen Y; Roberts AP; Wu Y; He R; Liang X; Qin M; Dai M; Zhang L; Li H; Yang F; Xu L; Tian GB
    mSphere; 2021 May; 6(3):. PubMed ID: 34011682
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vivo acquisition of bla
    Zhang P; Wang J; Shi W; Wang N; Jiang Y; Chen H; Yang Q; Qu T
    J Glob Antimicrob Resist; 2022 Dec; 31():189-195. PubMed ID: 36182079
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genomic characterization of a KPC-23-producing Klebsiella pneumoniae ST258 clinical isolate resistant to ceftazidime-avibactam.
    Galani I; Antoniadou A; Karaiskos I; Kontopoulou K; Giamarellou H; Souli M
    Clin Microbiol Infect; 2019 Jun; 25(6):763.e5-763.e8. PubMed ID: 30928562
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.